Rapid Detection Card Antigen Antibody

🧪 Rapid Test Kits (Antigen/Antibody Detection Cards)

🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition & Classification: What Exactly Are You Shipping?

Rapid Detection Cards (Antigen/Antibody) are diagnostic instruments used for point-of-care testing. In international trade, the classification depends heavily on the primary function and the nature of the reagents (biological vs. chemical).

Diagnostic Kits (Biological/Immunological): Contain specific antigens or antibodies as key reagents for immune reactions. Analytical Devices (Chemical/Physical): Used for general chemical or biochemical analysis, where the card is merely a substrate or device for measurement.

⚠️ Key Distinction Point:
- If the core value and function rely on specific biological recognition (Antigen-Antibody binding) for diagnosis → Classify under Chapter 30 (Pharmaceuticals/Biologicals) or 3822 (Diagnostic Reagents).
- If the item is viewed primarily as an instrumental device for chemical analysis → Classify under Chapter 90 (Optical/Scientific Instruments).

📦 II. HS Code Classification Details (2026 Latest Tariff Authority Comparison)

Based on the provided data, here are the four potential classifications for "Rapid Detection Cards" containing antigens/antibodies.

🔍 Critical Insight:
- The 10% tariff group (3002 & 3822) is based on the biological/diagnostic reagent nature of the product (Antigen/Antibody). This is generally the most accurate for rapid diagnostic kits (RDTs). - The 35% tariff group (9027) classifies the item as a general analytical instrument/device. This often results in higher duties and is typically used for equipment rather than single-use diagnostic cards.

💰 III. 2026 Latest Tariff Rate Breakdown (Including Surtaxes & Policy Add-ons)

✅ Applicable Country: United States (US)
✅ Country of Origin: China (CN)
✅ Effective Time: Post-2025 (Current 122-Clause Tariffs Apply)

🎯 1. The "Biological/Reagent" Group (3002.15.00.91, 3002.14.00.90, 3822.19.00.30)

📌 Explanation:
- These codes are favored for diagnostic kits because they attract a significantly lower total duty (10% vs 35%). - The 122-Clause tariff is a specific trade remedy duty applied to certain Chinese-origin goods. It is explicitly listed for these codes. - No 25% Section 301 tariff is applied here according to the provided data, making this the cost-effective classification route.

🎯 2. The "Analytical Instrument" Group (9027.89.80.30, 9027.89.45.30)

📌 Explanation:
- Classifying rapid tests as "analytical instruments" triggers the 25% Section 301 tariff. - Combined with the 10% 122-Clause tariff, the total duty hits 35%. - This classification is significantly more expensive and should only be used if the product is a reusable instrument, not a single-use diagnostic card.

🛠️ IV. Customs Clearance Practical Advice (Field Avoidance Guide)

✅ 1. Document Checklist (None of these are optional)

✅ 2. Declaration Strategy (Key Mantra)

🔥 "Highlight 'Diagnostic', Specify 'Antigen', Avoid 'Instrument'!"

📌 Tip:
- For Rapid Test Cards, always emphasize they are "Consumable Diagnostic Reagents". - Avoid words like "Machine," "Device," or "Analyzer" in the description unless referring to a separate electronic reader. - Use the term "Immunochromatographic Assay" to reinforce the biological/chemical reagent nature.

✅ 3. Special Circumstances

🌍 V. Global Market Comparison (2026 Latest)

📌 Conclusion:
- The USA is the most complex market due to the 122-Clause and potential Section 301 tariffs. - Correct classification under Chapter 38/30 saves 25% in duties compared to Chapter 90. - China-origin goods must budget for the 10% 122-Clause tariff regardless of the HS code chosen in the provided dataset.

📌 VI. Common Mistakes & Pitfalls (Blood Lessons)

❌ Mistake 1: Classifying a rapid test card as a "Testing Device" under 9027.
👉 Consequence: Duty jumps from 10% to 35% (+25% Section 301). Losing 25% profit margin!

❌ Mistake 2: Omitting "Contains Antigen" from the description.
👉 Consequence: Customs may reclassify as general chemical reagents or unclassified goods, leading to delays, audits, and potential penalties.

❌ Mistake 3: Not declaring the 122-Clause tariff compliance.
👉 Consequence: Even with a low base rate, the 10% 122-Clause is mandatory for Chinese origins. Failure to declare leads to seizure or fines.

❌ Mistake 4: Confusing "Reagent" with "Instrument".
👉 Consequence: A single-use card is NOT an instrument. It is a consumable. Misclassification leads to incorrect valuation and duty calculation.

✅ Correct Practice:

"Rapid Immunochromatographic Test Card for Antigen Detection, Containing Specific Antigens/Antibodies, For Diagnostic Use Only, Model XYZ, FDA Cleared."

🎯 VII. Conclusion: Professional Declaration, Save Costs, Ensure Clearance!

🎯 Remember the Mantra:

🔹 "Diagnostic Reagent, Not Instrument: 10% vs 35%."
🔹 "122-Clause Applies: Budget 10% for China Origin."
🔹 "Specify 'Antigen': Avoid Chapter 90 Traps."

📌 Pro Tip:
If your supply chain includes non-China origins (e.g., Southeast Asia), you may be able to avoid the 10% 122-Clause tariff, potentially lowering the total duty to 0% (if no Section 301 applies) or reducing costs significantly.
Apply for a Customs Ruling (Pre-Classification) before shipping to lock in the 10% duty rate and avoid clearance delays.

📣 Immediate Action:

📞 Contact your customs broker + Provide Reagent Formula + Request HS Code Pre-Ruling
🚀 Let your diagnostic kits clear smoothly, minimize costs, and maximize profit!

✨ Professional clearance starts with accurate classification!
💼 Every cent of duty saved is pure profit!